Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [2-, 11-, and 30-fold the maximum recommended human dose (MRHD) of 2 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (1-, 2-, and 7-fold MRHD) were administered to the females
This information is vital because it affects how they interpret any stomach pain or nausea you might report during your illness
Dairy ingredients aren't always obvious and can be hidden under different names
Behavior Genetics 34 :267-293
This flat-rate model eliminates the flat per-compound pricing that makes brand-name medications progressively more expensive as patients progress through their weight-loss journey
Explain that tirzepatide is a prescribed weekly injection for metabolic health